Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002

Amanda Langley, Nada K. Kakadadse, Stephen Swailes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.

Original languageEnglish
Pages (from-to)519-534
Number of pages16
JournalTechnology Analysis and Strategic Management
Volume17
Issue number4
DOIs
Publication statusPublished - Dec 2005
Externally publishedYes

Fingerprint Dive into the research topics of 'Grand Strategies and Strategic Actions in the Pharmaceutical Industry 2001– 2002'. Together they form a unique fingerprint.

  • Cite this